Ridgeline Discovery Revenue and Competitors

Basel, Swi

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ridgeline Discovery's estimated annual revenue is currently $12.1M per year.(i)
  • Ridgeline Discovery's estimated revenue per employee is $155,000

Employee Data

  • Ridgeline Discovery has 78 Employees.(i)
  • Ridgeline Discovery grew their employee count by 42% last year.

Ridgeline Discovery's People

NameTitleEmail/Phone
1
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.3M9237%N/AN/A
#2
$12.1M78-8%N/AN/A
#3
$61.7M39821%N/AN/A
#4
$12.2M7916%N/AN/A
#5
$10.2M662%N/AN/A
#6
$12.1M7842%N/AN/A
Add Company

What Is Ridgeline Discovery?

Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >50 highly experienced drug discovery professionals and built and operated several new successful companies, including Black Diamond Therapeutics (NASDAQ: BDTX), Bright Peak Therapeutics and Monte Rosa Therapeutics (NASDAQ: GLUE). Ridgeline is currently expanding its capabilities in Basel to support further company creation efforts in small molecules, biologics, and gene/cell therapy with focus on oncology and immunology.

keywords:N/A

N/A

Total Funding

78

Number of Employees

$12.1M

Revenue (est)

42%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.1M801%N/A
#2
$17.8M8147%N/A
#3
$21.9M8159%N/A
#4
N/A8113%N/A
#5
$18.4M8121%N/A